Beijing Konruns Pharmaceutical Co.,Ltd.

SHSE:603590 Stock Report

Market Cap: CN¥5.0b

Beijing Konruns PharmaceuticalLtd Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Jianhua Liu

Chief executive officer

CN¥605.0k

Total compensation

CEO salary percentagen/a
CEO tenure10.4yrs
CEO ownership32.5%
Management average tenureno data
Board average tenure10.4yrs

Recent management updates

Recent updates


CEO

Jianhua Liu (61 yo)

10.4yrs

Tenure

CN¥605,000

Compensation

Mr. Jianhua Liu is GM & Director of Beijing Konruns Pharmaceutical Co.,Ltd. from December 13, 2013.


Board Members

NamePositionTenureCompensationOwnership
Jianhua Liu
GM & Director10.4yrsCN¥605.00k32.45%
CN¥ 1.6b
Xijuan Wang
Chairman10.4yrsno data9.34%
CN¥ 465.8m
Xiaohan Liu
Director12.9yrsCN¥658.80kno data
Yonggong Zhai
Independent Director2.6yrsno datano data
Fang Fang
Supervisor2.6yrsno datano data
Ling Wang
Employee Representative Supervisor10.4yrsno datano data
Yun Zhou
Director2yrsno datano data

10.4yrs

Average Tenure

49yo

Average Age

Experienced Board: 603590's board of directors are seasoned and experienced ( 10.4 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.